Company: PTPI
Filing Date: 2025-01-24
Form Type: S-1
Source: 0001410578-25-000047
Chunk: 281

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-01-24
Form: S-1
Chunk 281
---
 Inline XBRL document                                                 |
| 101.SCH* |   | Inline XBRL Taxonomy Extension Schema Document                                                                                                                                                                        |
| 101.CAL* |   | Inline XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                                          |
| 101.DEF* |   | Inline XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                           |
| 101.LAB* |   | Inline XBRL Taxonomy Extension Labels Linkbase Document                                                                                                                                                               |
| 101.PRE* |   | Inline XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                                                                         |
| 107*     |   | Filing Fee Table.                                                                                                                                                                                                     |

| * | Filed herewith. |

| ** | To be filed by amendment. |

| ∞ | Certain of the schedules (and similar attachments) to these exhibits have been omitted in accordance with Regulation S-K Item 601(a)(5) of Regulation S-K under the Securities Act of 1933, as amended, because they do not contain information material to an investment or voting decision and that information is not otherwise disclosed in the exhibit or the disclosure document. The registrant hereby agrees to furnish a copy of all omitted schedules (or similar attachments) to the SEC upon its request. |

+Portions of these exhibits have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because they are both (i) not material and (ii) the type that the registrant treats as private or confidential. A copy of the omitted portions will be furnished to the SEC upon its request. †Management contract or compensatory plan or arrangement.

II-7

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in New York, New York, on the 24th day of January 2025.

| PETROS PHARMACEUTICALS, INC. |                                        |
| By:                          | /s/ Fady Boctor                        |
|                              | Fady Boctor                            |
|                              | President and Chief Commercial Officer |

POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Fady Boctor as his or her true and lawful attorneys-in-fact and agents, with the full power of substitution, for him or her and in his or her name